ArticleJournal of fluorescence2025
Development of a Charge-Mediated Disaggregation-Induced Fluorescence Enhancement Platform Using NS-Carbon Dots for Metformin Quantification and Pharmacokinetic Studies.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lateral flow assay for detecting aflatoxin B1 based on prussian blue nanoparticles.Mikrochimica acta · 2026Article
- Innovative Biosensor Platforms for the Detection of Metformin in Diabetes Management.International journal of analytical chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel ratiometric fluorometric sensor has been developed utilizing dual-emission nitrogen and sulfur co-doped carbon dots (NS-CDs) for the sensitive determination of metformin. The sensing mechanism relies on a unique disaggregation phenomenon observed under acidic conditions, where electrostatic repulsion between positively charged NS-CDs and metformin molecules leads to enhanced fluorescence emission. Upon metformin addition, the NS-CDs exhibit differential enhancement of their characteristic emission peaks, with the 562 nm peak showing markedly greater amplification than the 365 nm peak. This distinctive response enabled the development of a ratiometric detection approach using the F
Indexed as
Identifiers
39945987What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.